Ask AI
ProCE Banner Activity

APP Perspectives: Managing Toxicities With Bispecific Antibodies in Multiple Myeloma 

Slideset

Downloadable slideset on the identification and management of adverse events associated with BCMA and GPRC5D bispecific antibody therapy in multiple myeloma. The slideset highlights approaches to risk stratification, infection prevention, neurotoxicity monitoring, and CRS management, and emphasizes multidisciplinary coordination and the critical role of APPs in optimizing patient safety and outcomes.

Released: November 07, 2025

Share

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Johnson & Johnson.

Johnson & Johnson